Holen Sie sich die Stockscreener-App
1.69
0.60%
0.01
Handel nachbörslich:
1.61
-0.08
-4.73%
Schlusskurs vom Vortag:
$1.68
Offen:
$1.68
24-Stunden-Volumen:
155.26K
Relative Volume:
0.63
Marktkapitalisierung:
$90.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-2.0119
EPS:
-0.84
Netto-Cashflow:
$-18.45M
1W Leistung:
+2.42%
1M Leistung:
-2.31%
6M Leistung:
+20.71%
1J Leistung:
+212.67%
1-Tages-Spanne:
$1.63
$1.755
1-Wochen-Bereich:
$1.53
$1.93
52-Wochen-Spanne:
$0.525
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Firmenname
Quince Therapeutics Inc
Sektor
Branche
Telefon
415-910-5717
Adresse
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Vergleichen Sie QNCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.69 | 90.24M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Eingeleitet | Oppenheimer | Outperform |
Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten
Historical volatility pattern of Quince Therapeutics Inc. visualizedProfit Target & Fast Exit/Entry Strategy Plans - Newser
Analyzing recovery setups for Quince Therapeutics Inc. investorsInflation Watch & Consistent Return Investment Signals - Newser
Custom strategy builders for tracking Quince Therapeutics Inc.Earnings Overview Summary & Stock Portfolio Risk Management - Newser
Quince Therapeutics Inc. stock chart pattern explainedMarket Movement Recap & Consistent Profit Trading Strategies - Newser
What Fibonacci levels say about Quince Therapeutics Inc. reboundEarnings Overview Summary & Community Consensus Picks - Newser
Is Quince Therapeutics Inc. stock bottoming outWeekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
What institutional flow reveals about Quince Therapeutics Inc.Insider Selling & Free Expert Verified Stock Movement Alerts - Newser
Using RSI to spot recovery in Quince Therapeutics Inc.Portfolio Risk Report & Weekly Chart Analysis and Trade Guides - Newser
Is it time to cut losses on Quince Therapeutics Inc.July 2025 Sector Moves & Verified Short-Term Plans - Newser
Quince Therapeutics Reports Q2 2025 Financial Results - MSN
Exit strategy if you’re trapped in Quince Therapeutics Inc.Market Activity Recap & Risk Controlled Stock Pick Alerts - Newser
Quince, Niagen, Intrabio busy in rare A-T disease - BioWorld MedTech
Quince Therapeutics (NASDAQ:QNCX) Price Target Lowered to $8.00 at JMP Securities - Defense World
Is Quince Therapeutics Inc. stock poised for growthWeekly Trading Summary & Weekly Setup with ROI Potential - Newser
How Quince Therapeutics Inc. stock performs during market volatilityEarnings Risk Report & Verified Swing Trading Watchlists - Newser
Quince Therapeutics Inc. Stock Lags Behind Sector BenchmarksBreakout Entry Signal Confirmation Tool Used - 선데이타임즈
Quince Therapeutics stock price target lowered to $8 by Citizens JMP - Investing.com South Africa
Quince Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - BioSpace
What makes Quince Therapeutics Inc. stock price move sharplyEarnings Based Stock Performance Forecast - Newser
Should you hold or exit Quince Therapeutics Inc. nowFree Growth Based Investment Plan Guidance - Newser
Published on: 2025-08-11 03:02:40 - Newser
New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 2025Fast Movement Forecast for Trading Success - Newser
Quince Therapeutics Inc. stock prediction for this weekFree Accurate Technical Trend Reversal Picks - Newser
Quince Therapeutics (QNCX) Projected to Post Earnings on Tuesday - Defense World
Can trapped investors hope for a rebound in Quince Therapeutics Inc.Market Downturn Defense Strategy Analysis - Newser
Using data tools to time your Quince Therapeutics Inc. exitFree Stock Market Entry Timing Signals - Newser
Citizens Jmp Initiates Coverage on Quince Therapeutics (NASDAQ:QNCX) - Defense World
Quince Therapeutics (NASDAQ:QNCX) Research Coverage Started at Citizens Jmp - Defense World
Quince Therapeutics and the Strategic Partnership with Option Care Health: A Pathway to eDSP Commercialization and Market Expansion - AInvest
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP - The Globe and Mail
Is Quince Therapeutics Inc. a candidate for recovery playTrend Following Ideas with Volume Confirmation - Newser
Quince Therapeutics (NASDAQ:QNCX) Coverage Initiated by Analysts at JMP Securities - Defense World
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):